Previous 10 | Next 10 |
Intricon (NASDAQ:IIN) has entered into a definitive agreement whereby an affiliate of Altaris Capital Partners, an investment firm focused exclusively on the healthcare industry, will acquire the company. Under the terms, Altaris will acquire all outstanding shares of Intricon for $24.25/shar...
IntriCon press release (NASDAQ:IIN): Q4 Non-GAAP EPS of $0.23. Revenue of $32.2M (+6.3% Y/Y). For further details see: IntriCon Non-GAAP EPS of $0.23, revenue of $32.2M
ARDEN HILLS, Minn., Feb. 28, 2022 (GLOBE NEWSWIRE) -- Intricon Corporation (NASDAQ: IIN) , an international joint development manufacturer engaged in designing, developing, engineering, manufacturing, and packaging miniature interventional, implantable and body-worn medical devices, tod...
ARDEN HILLS, Minn., Feb. 28, 2022 (GLOBE NEWSWIRE) -- Intricon Corporation (NASDAQ: IIN) , an international joint development manufacturer engaged in designing, developing, engineering, manufacturing, and packaging miniature interventional, implantable and body-worn medical devices, tod...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Nowadays, you hear a lot about “quants.” Plenty of “quant” firms have popped up on Wall Street over the years. Source: Shutterstock I’m proud to say that I’ve been using the...
ARDEN HILLS, Minn., Nov. 09, 2021 (GLOBE NEWSWIRE) -- Intricon Corporation (NASDAQ: IIN), an international joint development manufacturer engaged in designing, developing, engineering, manufacturing, and packaging miniature interventional, implantable and body-worn medical devices, toda...
IntriCon Corporation (IIN) Q3 2021 Earnings Conference Call November 8, 2021 17:00 ET Corporate Participants Scott Longval - President and Chief Executive Officer Annalee Lutgen - Interim Chief Financial Officer Conference Call Participants Tom Stephan - Stifel Kyle Bauser - Colliers Securiti...
IntriCon (NASDAQ:IIN): Q3 Non-GAAP EPS of $0.17 beats by $0.14. Revenue of $31.05M (+13.4% Y/Y) misses by $0.05M. Press Release For further details see: IntriCon EPS beats by $0.14, misses on revenue
ARDEN HILLS, Minn., Nov. 08, 2021 (GLOBE NEWSWIRE) -- Intricon Corporation (NASDAQ: IIN) , an international joint development manufacturer engaged in designing, developing, engineering, manufacturing, and packaging miniature interventional, implantable and body-worn medical devices, tod...
IntriCon Corporation (IIN -1.0%) projected ~$31.1M as the company’s preliminary revenue forecast for Q3 2021. The early estimate stands ~13.5% higher than the prior-year period, while the consensus estimate for the third quarter indicates ~$29.7M revenue for the company in Q3...
News, Short Squeeze, Breakout and More Instantly...
ARDEN HILLS, Minn., May 24, 2022 (GLOBE NEWSWIRE) -- Intricon Corporation (NASDAQ: IIN), an international joint development manufacturer engaged in designing, developing, engineering, manufacturing, and packaging miniature interventional, implantable and body-worn medical devices, toda...
IntriCon Corporation (NASDAQ:IIN) traded today at a new 52-week high of $76.80. Approximately 8.6 million shares have changed hands today, as compared to an average 30-day volume of 199,000 shares. IntriCon Corp is an international company and joint development manufacturer (JDM) of micr...
Check Out These Health Care Stocks In The Stock Market Today Given the current volatility in the market, some investors may be looking to rotate into lower-risk sectors of the stock market . Hence, health care stocks could be worth considering. This is because regardless of the ...